CT
Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
$0.58 +1.47% (+$0.01)
1M -8.01%
Market Cap $6.37M
P/E Ratio -
Div. Yield -
ROE 71.58%
Bulios Fair Price
$0.76
31.4% upside
Trenutna cena
$0.58
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CTXR trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.90x
P/B 0.10x
P/E N/A
Growth
0 /100
Declining Book val. growth 13.07%
EPS growth N/A
Rev. growth N/A
Profitability
18 /100
Weak Gross margin 44.19%
Net margin 694.29%
FCF margin 444.69%
Quality
1 /100
Poor ROIC 67.29%
ROE 71.58%
Asset turnover 0.05x
Debt
52 /100
Moderate Debt/Equity 0.11x
Current ratio 0.84x
Int. coverage -947.30x
Stability
63 /100
Moderate Beta 1.00x
EPS volatility 26.69%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CTXR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Leonard L. Mazur
Employees
23
Headquarters
Cranford
Prihajajoči dogodki
17 DEC.
Earnings
Upcoming earnings report
22 DEC.
Earnings
Upcoming earnings report